View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Legacy Housing Corporation Reports Third Quarter 2024 Financial Result...

Legacy Housing Corporation Reports Third Quarter 2024 Financial Results BEDFORD, Texas, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Legacy Housing Corporation (“Legacy” or the “Company,” NASDAQ: LEGH) today announced its financial results for the third quarter ended September 30, 2024. Financial Highlights Net revenue for the third quarter of 2024 was $44.3 million, a decrease of 11.4% from the third quarter of 2023.Income from operations for the third quarter of 2024 was $15.3 million, a decrease of 19.4% from the third quarter of 2023.Net income for the third quarter of 2024 was $15.8 million, ...

 PRESS RELEASE

Nkarta to Participate in an Upcoming Investor Conference

Nkarta to Participate in an Upcoming Investor Conference SOUTH SAN FRANCISCO, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference: Stifel 2024 Healthcare ConferenceNovember 19, 202410:55 a.m. ET – fireside chat A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, , and a replay will be archived on the website for approximately 90 days. About NkartaNkarta is a clinica...

 PRESS RELEASE

Nkarta Reports Third Quarter 2024 Financial Results and Corporate High...

Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights First patient dosed in each of Ntrust-1 and investigator-sponsored clinical trial (IST) of NKX019; enrollment ongoing in both studiesEnrollment in Ntrust-2 expected to initiate by year-end 2024 Preliminary clinical data from Ntrust-1 and Ntrust-2 clinical trials planned for 2025No further NKX019 development in lymphoma planned Platform prioritized to focus on advancement of NKX019 for multiple autoimmune diseases Cash balance of $405.3 million on September 30, 2024, including cash, cash equivalents and investments,...

 PRESS RELEASE

Legacy Housing Corporation Announces Timing of Third Quarter 2024 Earn...

Legacy Housing Corporation Announces Timing of Third Quarter 2024 Earnings Release and Conference Call BEDFORD, Texas, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Legacy Housing Corporation (“Legacy” or the “Company”, NASDAQ: LEGH) will release its financial results for the third quarter ended September 30, 2024, after markets close on Tuesday, November 12, 2024. The Company will then host a conference call at 10:00 a.m. Central Time on Wednesday, November 13, 2024. To access the conference call, please pre-register using this . Registrants will receive confirmation with dial-in details. A replay...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Nkarta to Participate in Upcoming Investor Conference

Nkarta to Participate in Upcoming Investor Conference SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference: H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 10, 202412:30 p.m. ET – fireside chat A simultaneous webcast of each event will be available on the Investors section of Nkarta’s website, , and a replay will be archived on the website for approximately 90 days. About Nk...

 PRESS RELEASE

Correction: Nkarta Reports Second Quarter 2024 Financial Results and C...

Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights Enrollment expected to initiate by year-end 2024 in second clinical trial of NKX019 in autoimmune disease, Ntrust-2, for treatment of systemic sclerosis, myositis and vasculitisPreliminary clinical data from Ntrust-1 and Ntrust-2 clinical trials planned for 2025Cash balance of $426.7 million on June 30, 2024, including cash, cash equivalents and investments, expected to fund operations into late 2027 This press release was updated to reflect the correct dosing schedule of the NKX019 investigator-spons...

 PRESS RELEASE

Nkarta Reports Second Quarter 2024 Financial Results and Corporate Hig...

Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights Enrollment expected to initiate by year-end 2024 in second clinical trial of NKX019 in autoimmune disease, Ntrust-2, for treatment of systemic sclerosis, myositis and vasculitisPreliminary clinical data from Ntrust-1 and Ntrust-2 clinical trials planned for 2025Cash balance of $426.7 million on June 30, 2024, including cash, cash equivalents and investments, expected to fund operations into late 2027 SOUTH SAN FRANCISCO, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage bio...

Brian Violino ... (+2)
  • Brian Violino
  • Jay McCanless
Wedbush Research
  • Wedbush Research
GEO GEO GROUP INC. (THE)
ADS ADIDAS AG
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SBRA SABRA HEALTH CARE REIT INC.
SAGE SAGE THERAPEUTICS INC.
PZZA PAPA JOHN'S INTERNATIONAL INC.
PSTG PURE STORAGE INC. CLASS A
OHI OMEGA HEALTHCARE INVESTORS INC.
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
NHI NATIONAL HEALTH INVESTORS INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
MFA MFA FINANCIAL INC.
LTC LTC PROPERTIES INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
GPC GENUINE PARTS COMPANY
FL FOOT LOCKER INC.
EXPE EXPEDIA GROUP INC.
DKS DICK'S SPORTING GOODS INC.
CYBR CYBERARK SOFTWARE LTD.
CXW CORECIVIC INC.
CTRE CARETRUST REIT INC
CTMX CYTOMX THERAPEUTICS INC.
BIIB BIOGEN INC.
AXTI AXT INC.
ARDX ARDELYX INC
AAP ADVANCE AUTO PARTS INC.
WD WALKER & DUNLOP INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
UAA UNDER ARMOUR INC. CLASS A
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
NKE NIKE INC. CLASS B
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
BKNG BOOKING HOLDINGS INC.
RCUS ARCUS BIOSCIENCES
HEAR TURTLE BEACH CORP.
REPL REPLIMUNE GROUP
LEGH LEGACY HOUSING CORP
CRWD CROWDSTRIKE HOLDINGS INC. CLASS A
STOK STOKE THERAPEUTICS
DDOG DATADOG INC CLASS A
SMCI SUPER MICRO COMPUTER
U INC.
ABNB UNITY SOFTWARE
PLTR AIRBNB INC. CLASS A
VOR PALANTIR TECHNOLOGIES
BUR VOR BIOPHARMA
CGEM BURFORD CAPITAL
GHLD CULLINAN ONCOLOGY INC
FHTX GUILD HOLDINGS
LBPH FOGHORN THERAPEUTICS
ONON LONGBOARD PHARMACEUTICALS
STX ON HOLDING AG
IKNA SEAGATE TECHNOLOGY HLDGS PLC
APP IKENA ONCOLOGY INC
TTD APPLOVIN CORP
CCSI THE TRADE DESK
GFS INC.
GMTX CONSENSUS CLOUD SOLUTIONS INC
SOUN GLOBALFOUNDRIES INC
EWTX GEMINI THERAPEUTICS INC
DNTH SOUNDHOUND AI INC
EDGEWISE THERAPEUTICS INC
DIANTHUS THERAPEUTICS INC
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch